NCT03991455 is a NA clinical trial of Apyx device in Pelvic Organ Prolapse, sponsored by Escala Medical LTD.

Who is sponsoring NCT03991455?

NCT03991455 is sponsored by Escala Medical LTD.

What drugs are being tested in NCT03991455?

Interventions in NCT03991455: Apyx device.

What condition does NCT03991455 study?

NCT03991455 studies Pelvic Organ Prolapse.

Is NCT03991455 still recruiting?

NCT03991455 is currently completed. Last updated 27 July 2022.

Last reviewed 2022-07-27 · How we verify

NCT03991455

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Safety and Efficacy of the Apyx™ Device for the Repair of Pelvic Organ Prolapse (POP)

Completed NA Last updated 27 July 2022

What this trial tests

NA trial testing Apyx device in Pelvic Organ Prolapse in 17 participants. Completed in 1 May 2022.

Timeline

25 October 2019

Primary endpoint
1 May 2022

1 May 2022

Quick facts

Lead sponsor	Escala Medical LTD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	25 October 2019
Primary completion	1 May 2022
Estimated completion	1 May 2022
Sites	1 location across Israel

Drugs / interventions tested

Apyx device

Conditions studied

Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →

Sponsor

Escala Medical LTD

Who can join

Adults 18 to 90, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to further evaluate this minimally invasive SSLF technique with respect to safety, clinical effectiveness, and patient satisfaction. The procedure will be performed in women electing to undergo surgical repair of their prolapse who wish to preserve their uterus, and will be evaluated using standardized measures and questionnaires.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
NCT07218016 — The AccelERate Trial · NA · recruiting
NCT07114029 — VNOTES Approach in Mesh Free Sacrocolpopexy: A Functional and Anatomic Evaluation · NA · recruiting
NCT07082023 — Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03991455 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Escala Medical LTD
Last refreshed: 27 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03991455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing